Trending Topic

6 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Grace Johanna Salazar Tamayo

Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control can only be achieved with various measures applied continuously and consistently by a group of […]

Paul Heath: Phase 3 trial of Novavax Investigational COVID-19 vaccine [Part 1]

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 20th 2021

It was a great pleasure to meet with Prof. Paul Heath (St George’s, University of London, London, UK) to discuss the findings from the Phase III Novavax clinical trial that is investigating the safety and efficacy of NVX-CoV2373, a vaccine candidate for COVID-19. Please find Part 2 of this interview available here.

To access more COVID-19 content, please visit our COVID-19 Hub.

Questions:

  1. What is the design of the Novavax vaccine, and how is it stored and administered? (0:25)
  2. Could you give us a brief overview of the Phase III Novavax clinical trial? (2:03)
  3. What were the safety findings of the study? (8:02)
  4. What questions remain unanswered about the vaccine efficacy and safety? (10:19)

Disclosures: Paul Heath has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup